UCme Bioscience is developing a new anti-angiogenic antibody of its own invention for the therapy of diseases with a neovascular component, such as diabetic retinopathy and age-related macular degeneration, for which the treatments currently used do not lead to a complete and lasting cure. Since ang... Read more
This company has no org chart yet
This company has no teams yet
This company has no offices yet